| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |